Patients should maintain open communication with their healthcare team throughout semaglutide treatment
Unfortunately, there was no comparison with an 'in person' visit, as likely their conclusions would then be a bit more objective ("Nevertheless, while direct-to-consumer platforms have increased patient access to GLP-1 RAs, these findings suggest that some do so through impersonal care that prioritizes quick prescriptions over comprehensive care")
Altintas also noted that if these findings are confirmed by prospective studies, several important clinical implications emerge. First, clinicians may be less concerned that semaglutide-induced weight loss inherently increases fracture risk in patients with type 2 diabetes
Diabetic retinopathy Retinal bleeding and blindness have occurred, typically with the coadministration of insulin
A network meta-analysis comparing multiple weight loss approaches found semaglutide achieves 13.7% average weight loss compared to phentermine combined with topiramate at 9.1%